Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Single vs Multiple Visit Regeneration in Necrotic Immature Teeth
NCT04533074Phase 2Terminated
- Start
- Aug 2018
- Primary completion
- Mar 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of calcium hydroxide in pulp necrosis. Primary endpoints: Microbiological assessment using MALDI-TOF MS at 24 hours and Tooth vitality at 12 months. Started Aug 2018; status: terminated.
02
Drugs
calcium hydroxide
03
Conditions
pulp necrosis
Beyond the preview
Go deeper on NCT04533074.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04533074.